Photosynth Res 42(3):167–168 Stanier, Roger (1916–1982) Ingraham

Photosynth Res 42(3):167–168 Stanier, Roger (1916–1982) Ingraham JL (1982) Roger Y. Stanier (1916–1982). Arch Mikrobiol 133(1):1 Ken-ichiro Takamiya (1943–2005) Ohta H, Masuda T, Matsuura K (2008) Ken-ichiro Takamiya (1943–2005), a gentleman and a scientist, a superb experimentalist and a visionary. Photosynth Res 97(2):115–119 Hiroshi Tamiya (1903–1986) Sestak Z (1986) 4SC-202 nmr Hiroshi Tamiya (1903–1986). Photosynthetica 20:81 Vidyadhar G. (Pandit) Tatake (1926–2004) Sane PV (Raj), Phondke GP (Bal) (2006) Vidyadhar Govind (Pandit) Tatake (1926–2004): an ingenious instrumentalist, an authority on thermoluminescence, and a lover of classical

Indian music. Photosynth Res 89(1):49–51 Jan Bartholomeus Thomas (1907–1991) van Ginkel G, Goedheer

J (1991) Jan Bartholomeus Thomas (1907–1991). Photosynth Res APR-246 solubility dmso 30(2–3):65–69 Philip Thornber (1934–1996) Cogdell R (1996) Philip Thornber (1934–1996). Photosynth Res 50(1):1–3 Nathan Edward Tolbert (1919–1998) Goyal A (2000) Ed Tolbert and his love for science: a journey from sheep ranch continues…. Photosynth Res 65(1):1–6 Cornelis Bernardus van Niel (1897–1985) Hungate RE (1986) Cornelis Bernardus van Niel (1897–1985). Photosynth Res 10(1–2):139–142 Ilya Vassiliev (1959–2005) Barry BA (2006) Ilya Vassiliev (January 12, 1959–August 10, 2005). Photosynth Res 87(3):245–246 Birgit Vennesland (1913–2001) Conn EE, Pistorius EK, Solomonson LP (2005) Remembering Birgit Vennesland (1913–2001), a great biochemist. Photosynth Res 83(1):11–16 Hemming Virgin (1918–2005) Sundqvist C, Björn LO (2007) A tribute to Hemming Virgin (1918–2005), a Swedish pioneer in plant photobiology. Photosynth ID-8 Res 92(1):13–16 E.C. Wassink (1904–1981) Vredenberg WJ (1981) Professor Dr. E.C. Wassink (1904–1981). Photosynthetica 15:315–316 Samuel G. Wildman (1912–2004) Tobin E (2006) Samuel Goodnow Wildman (1912–2004): discoverer of fraction I protein, later named Rubisco, who worked till he was 92. Photosynth Res 88(2):105–108 Horst

T. Witt (1922–2007) Renger G (2008) Horst Tobias Witt (March 1, 1922–May 14, 2007). Photosynth Res 96(1):5–8 René Wurmser (1890–1993) Joliot P (1996) René Wurmser (September 24, 1890–November 9, 1993). Photosynth Res 48(3):321–323 2 II Recognitions William A. Arnold Duysens LNM (1996) W.A. Arnold’s inspiring experiments. Photosynth Res 48(1–2):25–29 Knox RS (1996) Electronic excitation transfer in the photosynthetic unit: reflections on work of William Arnold. Photosynth Res 48(1–2):35–39 Lavorel J (1996) The importance of being lucky: a tribute to William Arnold. Photosynth Res 48(1–2):31–34 Malkin S, Fork DC (1996) Bill Arnold and calorimetric GSK2126458 cell line measurements of the quantum requirement of photosynthesis-once again ahead of his time. Photosynth Res 48(1–2):41–46 Mauzerall D (1996) Bill Arnold’s concept of solid state photosynthesis and his discoveries. Photosynth Res 48(1–2):19–23 Daniel I.

To cross-correlate

To cross-correlate Torin 1 in vitro between the secretome and proteome data sets, we first searched for Leishmania orthologs in T. brucei using BLAST (Basic Local Alignment Search Tool) analysis. 281 out of the 358 Leishmania secretome entries were found to have an ortholog in Trypanosoma (additional file 3, Table S3), including 115 actively secreted proteins and 166 cell-associated proteins. Interestingly, a high proportion (61%) of the former was present in our Trypanosoma secretome, suggesting a close relationship between the actively secreted proteins in Leishmania

and the Trypanosoma secreted proteins. In contrast, only 8% of the Trypanosoma secretome was shared with the glycosome proteome (additional file 4, Table S4). We also compared the LOXO-101 datasheet trypanosome total proteome (additional file 5, Table S5) and the secretomes from Trypanosoma and Leishmania. Figure 5 shows that 41% and 39%, respectively, of the trypanosome and Leishmania secretomes were not shared with any of the other proteomes. Simultaneously, secretome proteins shared with

see more the Trypanosoma total proteome amounted to 47% and 43% for Trypanosoma and Leishmania, respectively, indicating that a major part of these secretomes resulted from an active secretion process. Figure 5 Overlap between Trypanosoma total proteome and the T. brucei gambiense and L. donovanii secretome. Proteins identified in 3 different compartments (T. brucei total proteome, T. brucei gambiense secretome, and L. donovanii secretome) were compared as to determine part of the proteins that were either specific to each compartment or common to different compartments. So, the black circle in the middle shows that 84 proteins others are common to T. brucei total proteome, T. brucei gambiense secretome, and L. donovanii secretome. Among the other proteins of the T. brucei gambiense secretome, for example, 182 (41%) were specific to this compartment, whereas 52 were common with L. donovanii secretome, and 126 with the total

proteome; out of the proteins identified in the total T. brucei proteome, 824 were specific to this compartment. Finally, these different proteomes were compared at the functional level (Figure 6; additional files 1, 2, 3, 4 and 5, Tables S1-S5). Interestingly, the two secretomes showed large similarities with almost the same proportion of proteins involved in folding and degradation and protein synthesis or with unassigned function. In contrast, the comparison between secretomes and glycosome functional categories showed major differences, the glycosome proteome displaying an expected bias toward sugar (15%) and lipid metabolism (7%) and, more surprisingly, toward nucleotide metabolism (7%). Also, the total proteome differed from all sub-proteomes by a deeper investment in cell organization and RNA/DNA metabolism.

For Ecol Manag 259:2133–2140CrossRef Guo LB, Gifford RM (2002) So

For Ecol Manag 259:2133–2140CrossRef Guo LB, Gifford RM (2002) Soil carbon stocks and land use change: a meta analysis. Glob Chang Biol 8:345–360CrossRef Hartley MJ (2002) Selleckchem Screening Library Rationale and methods for conserving biodiversity in plantation forests. For Ecol Manag 155:81–95CrossRef Hecht SB, Kandel S, Gomes I, Cuellar N, Rosa H (2006) Globalization, forest resurgence, and environmental politics in El Salvador. World Dev 34:308–323CrossRef Herault B, Bouxin G, Thoen D (2004) Comparison of the regeneration patterns of woody species between Norway spruce BGB324 cell line plantations and deciduous forests on alluvial soils. Belg J Bot 137:36–46 Hobbs R, Catling PC, Wombey JC, Clayton M, Atkins

L, Reid A (2003) Faunal use of bluegum (Eucalyptus globulus) plantations in southwestern Australia. Agrofor Syst 58:195–212CrossRef Humphrey JW (2005) Benefits to biodiversity from developing old-growth conditions in British upland spruce plantations: a review and recommendations. Forestry 78:33–53CrossRef Humphrey JW, Hawes C, Peace AJ, Ferris-Kaan R, Jukes MR (1999) Relationships between insect diversity and habitat characteristics in plantation forests. For Ecol Manag 113:11–21CrossRef Igboanugo ABI, Omijeh JE, Adegbehin JO (1990) Pasture floristic composition in different

eucalyptus species plantations in some parts of Northern Guinea Savanna Zone of Nigeria. Agrofor Syst 12:257–268CrossRef Ito S, Nakayama R, Buckley GP (2004) Effects of previous Selleck CHIR98014 land-use on plant oxyclozanide species diversity in semi-natural and plantation forests in a warm-temperate region in southeastern Kyushu, Japan. For Ecol Manag 196:213–225CrossRef Kanowski J, Catterall CP, Wardell-Johnson

GW, Proctor H, Reis T (2003) Development of forest structure on cleared rainforest land in eastern Australia under different styles of reforestation. For Ecol Manag 183:265–280CrossRef Koonkhunthod N, Sakurai K, Tanaka S (2007) Composition and diversity of woody regeneration in a 37-year-old teak (Tectona grandis L.) plantation in Northern Thailand. For Ecol Manag 247:246–254CrossRef Lamb D (1998) Large-scale ecological restoration of degraded tropical forest lands: the potential role of timber plantations. Restor Ecol 6:271–279CrossRef Lambin EF, Meyfroidt P (2010) Land use transitions: socio-ecological feedback versus socio-economic change. Land Use Policy 27:108–118CrossRef Lantschner M, Rusch V, Peyrou C (2008) Bird assemblages in pine plantations replacing native ecosystems in NW Patagonia. Biodivers Conserv 17:969–989CrossRef Lee EWS, Hau BCH, Corlett RT (2005) Natural regeneration in exotic tree plantations in Hong Kong, China. For Ecol Manag 212:358–366CrossRef Lemenih M, Teketay D (2005) Effect of prior land use on the recolonization of native woody species under plantation forests in the highlands of Ethiopia.

A multicentre randomised controlled trial BMC Musculoskelet Diso

A multicentre randomised controlled trial. BMC Musculoskelet Disord 2011,24(12):196.CrossRef 5. American College of Surgeons: Advanced trauma life support for doctors. Student course manual. 7th edition. Chicago, IL: American College of surgeons; 2004. 6. Aukema TS, Beenen LF, Hietbrink F, Leenen LPH: Initial assessment of chest X-ray in thoracic trauma

patients: awareness of specific injuries. SIS 3 World J Radiol 2012,4(2):48–52. doi: 10.4329/wjr.v4.i2.48PubMedCrossRef 7. Livingston DH, Shogan B, John P, Lavery RF: CT diagnosis of Rib fractures and the prediction of acute respiratory failure. J Trauma 2008,64(4):905–911. United StatesPubMedCrossRef 8. Spijkers ATE, Meylaerts SAG, Leenen LPH: Mortality Decreases by Implementing a Level I Trauma Center in a Dutch Hospital. J Trauma-Injury Infect Crit Care 2010,69(5):1138–1142.CrossRef 9. Committee on Injury Scaling: The Abbreviated Injury Scale, 1998 revision (AIS-98). Des Plaines (IL): Association

for the Advancement learn more of Automotive Medicine; 1998. 10. Baker SP, O’Neill B, Haddon W, Long WB: The injury severity score: a method for describing patients with multiple injuries and PR-171 molecular weight evaluating emergency care. J Trauma 1974,14(3):187–196. United StatesPubMedCrossRef 11. American College of Surgeons: Resources for the Optimal Care of the Injured Patient. Chicago, IL; 1987. 12. Robinson CM: Fractures of the clavicle in the adult. Epidemiology and classification. J Bone Joint Surg Br 1998,80(3):476–484.PubMedCrossRef 13. Nowak J, Mallmin H, Larsson S: The aetiology and epidemiology of

clavicular fractures. A prospective study during a two-year period in Uppsala, Sweden. Injury 2000, 31:353–358.PubMedCrossRef 14. Stanley D, Trowbridge EA, Norris SH: The mechanism of clavicular fracture. A clinical and biomechanical analysis. J Bone Joint Surg Br 1988,70(3):461–464.PubMed 15. McKee MD, Schemitsch EH, Stephen DJ, Kreder HJ, Yoo D, Harrington J: Functional outcome following clavicle fractures in polytrauma patients [abstract]. J Trauma 1999, Doxorubicin manufacturer 47:616. 16. Baldwin KD, Ohman-Strickland P, Mehta S, Hume E: Scapula fractures: a marker for concomitant injury? A retrospective review of data in the National Trauma Database. J Trauma 2008,65(2):430–435. United StatesPubMedCrossRef 17. Gottschalk HP, Browne RH, Starr AJ: Shoulder girdle: patterns of trauma and associated injuries. J Orthop Trauma 2011,25(5):266–271. United StatesPubMedCrossRef 18. Horst K, Dienstknecht T, Pfeifer R, Pishnamaz M, Hildebrand F, Pape HC: Risk stratification by injury distribution in polytrauma patients — does the clavicular fracture play a role? Patient Saf Surg 2013,7(1):23.PubMedCrossRef Competing interests The authors declare that they have no competing interests.

Int J Antimicrob Agents 2008, 32:130–138 PubMedCrossRef 40 Deslo

Int J Antimicrob Agents 2008, 32:130–138.PubMedCrossRef 40. Deslouches B, Phadke SM, PR-171 in vivo Lazarevic V, Cascio M, Islam K, Montelaro RC, et al.: De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother 2005, 49:316–322.PubMedCrossRef 41. Wu M, Hancock RE: Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J Biol Chem 1999, 274:29–35.PubMedCrossRef 42. Phadke SM, Lazarevic V, Bahr CC, Islam K, Stolz DB,

Watkins S, et al.: Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens. Antimicrob Agents Chemother 2002, 46:2041–2045.PubMedCrossRef 43. Loit E, Hincke MT, Altosaar I: Synthetic antimicrobial peptide L8 (MHLHKTSRVTLYLL) has membrane permeabilisation and bacterial aggregation activity. Int J Antimicrob Agents 2010, 35:410–411.PubMedCrossRef 44. Harms JM, Bartels H, Schlunzen F, Yonath A: Antibiotics acting on the translational machinery. J Cell Sci

2003, 116:1391–1393.PubMedCrossRef 45. Schmitz FJ, Higgins PG, Mayer S, Fluit AC, Dalhoff A: Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur SB431542 cell line J Clin Microbiol Infect Dis 2002, 21:647–659.PubMedCrossRef 46. Reynolds PE: Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 1989, 8:943–950.PubMedCrossRef 47. Tsang JC, Weber DA, Brown DA: Evidences for complex formation between polymyxin B and lipopolysaccharides from Serratia marcescens. J Antibiot (Tokyo) 1976, 29:735–742. 48. Hancock RE: The bacterial outer membrane as a drug barrier. Trends Microbiol 1997, 5:37–42.PubMedCrossRef 49. Epand RM, Epand RF: Bacterial membrane lipids in the action of antimicrobial agents. J Pept Sci

2010. 50. Hancock RE, Chapple DS: Peptide antibiotics. Antimicrob Agents Chemother 1999, 43:1317–1323.PubMed 51. Bechinger B: The structure, Cediranib (AZD2171) dynamics and orientation of antimicrobial peptides in membranes by multidimensional Go6983 research buy solid-state NMR spectroscopy. Biochim Biophys Acta 1999, 1462:157–183.PubMedCrossRef 52. Koo SP, Yeaman MR, Nast CC, Bayer AS: The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. Infect Immun 1997, 65:4795–4800.PubMed 53. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, et al.: Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 2010, 328:1168–1172.PubMedCrossRef 54. Casteels P, Tempst P: Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. Biochem Biophys Res Commun 1994, 199:339–345.PubMedCrossRef 55. Zaknoon F, Sarig H, Rotem S, Livne L, Ivankin A, Gidalevitz D, et al.: Antibacterial properties and mode of action of a short acyl-lysyl oligomer. Antimicrob Agents Chemother 2009, 53:3422–3429.

J Ferment Bioeng 1997, 84:1–6 CrossRef 3 Haakensen M, Schubert A

J Ferment Bioeng 1997, 84:1–6.CrossRef 3. Haakensen M, Schubert A, Ziola B: Multiplex PCR for putative Lactobacillus and Pediococcus beer-spoilage genes and ability of gene presence to predict growth in beer. J Am Soc Brew Chem 2008,66(2):63–70. 4. Haakensen MC, Butt L, Chaban B, Deneer H, Ziola B, Dowgiert T: A horA -specific real-time PCR for detection of beer-spoilage lactic acid bacteria. J Am Soc Brew Chem 2007,65(3):157–165. 5. Haakensen M, Shubert

A, Ziola B: Broth and agar hop-gradient plates used to evaluate the beer-spoilage potential of Lactobacillus and Pediococcus isolates. Int J Food Microbiol 2009,130(1):56–60.CrossRefPubMed 6. Haakensen M, Pittet V, Morrow K, Schubert A, Ferguson J, Ziola B: Ability of novel ATP-binding cassette multidrug resistance GANT61 cost genes to predict growth of Pediococcus isolates in beer. J Am Soc Brew Chem 2009,67(3):170–176.

7. Hayashi N, Ito M, Horiike S, Taguchi H: Molecular cloning of a putative divalent-cation transporter gene as a new genetic marker for the identification of Lactobacillus brevis strains capable of growing in beer. Appl Microbiol Biotechnol 2001,55(5):596–603.CrossRefPubMed 8. Iijima check details K, Suzuki K, Ozaki K, Yamashita H:horC GM6001 supplier confers beer-spoilage ability on hop-sensitive Lactobacillus brevis ABBC45cc. J Appl Microbiol 2006,100(6):1282.CrossRefPubMed 9. Fujii T, Nakashima K, Hayashi N: Random amplified polymorphic DNA-PCR based cloning of markers to identify the beer-spoilage strains of Lactobacillus brevis, Pediococcus damnosus, Lactobacillus collinoides and Lactobacillus coryniformis. J Appl Microbiol 2005,98(5):1209–1220.CrossRefPubMed 10. Klare I, Konstabel C, Werner G, Huys G, Vankerckhoven V, Kahlmeter G, Hildebrandt B, Muller-Bertling S, Witte W, Goossens H: Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates

and cultures intended for probiotic or nutritional use. J Antimicrob Chemother 2007,59(5):900–912.CrossRefPubMed 11. Klare I, Konstabel C, Muller-Bertling S, Reissbrodt R, Huys G, Vancanneyt M, Swings J, Herman G, Witte W: Evaluation of new broth media for microdilution antibiotic susceptibility testing of lactobacilli, pediococci, lactococci, and bifidobacteria. Adenosine triphosphate Appl Environ Microbiol 2005,71(12):8982–8986.CrossRefPubMed 12. Ammor MS, Belén FA, Mayo B: Antibiotic resistance in non-enterococcal lactic acid bacteria and Bifidobacteria. Food Microbiol 2007,24(6):559–570.CrossRefPubMed 13. Danielsen M, Simpson PJ, O’Connor EB, Ross RP, Stanton C: Susceptibility of Pediococcus spp. to antimicrobial agents. J Appl Microbiol 2007,102(2):384–389.CrossRefPubMed 14. Tankovic J, Leclercq R, Duval J: Antimicrobial susceptibility of Pediococcus spp. and genetic basis of macrolide resistance in Pediococcus acidilactici HM3020. Antimicrob Agents Chemother 1993,37(4):789–792.PubMed 15.